ACGT and Chromatin jointly announced their intent to pursue a long-term research agreement to develop mini-chromosome technology on 5/5/10. ACGT is a wholly-owned subsidiary of Genting Plantations Berhad, the plantation unit of the Genting Group, one of Asia’s leading conglomerates (www.genting.com). ACGT is a center of excellence in genomic science, focused on the application of genome technology to improve crop plants for sustainable food and fuel. The signing ceremony was witnessed by the Minister of Science, Technology, and Innovation Malaysia at the BIO International conference in Chicago. “This collaborative relationship with ACGT strengthens Chromatin’s business links with Malaysia, which began in late 2008 with an investment from The Malaysian Life Sciences Capital Fund,” said Chromatin CEO, Daphne Preuss. “Chromatin looks forward to a mutually beneficial partnership with ACGT to develop biotech solutions which can increase productivity and enhance value creation for multiple crops,” said Preuss. Chromatin moved its Champaign R&D operation to the Graduation Building in the Research Park to a new custom facility in April 2010.